We previously reported that glomerular TNF expression in patients with primary FSGS correlates with loss of GFR[19], and our extensive microarray analysis of several cohorts with patients affected by FSGS in this study confirmed an important role of the TNF signaling pathway as a pathway that is activated prior to the clinical manifestation of the disease. The gene discussed is TNF; the disease is focal segmental glomerulosclerosis.